NICE, France--(BUSINESS WIRE)--Iris Pharma, a world renowned contract research organisation specialising in preclinical and clinical ophthalmology research, has announced that it has just enhanced its equipment pool by acquiring a Spectralis® HRA+OCT and a Luminex® Lx200 IS analysis system.
